Related Experiment Video
Updated: Jul 28, 2025
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
483
[Latest Findings on Long Noncoding RNA in Tumor Microenvironment]
Juan Jin1, Xiao-Xiao Zhao1, Li Li1
1Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
Summary
Long noncoding RNAs (lncRNAs) are key regulators in the tumor microenvironment, influencing cancer progression. Further research into lncRNA targeting and delivery is crucial for developing novel cancer diagnostics and therapeutics.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Context:
- The tumor microenvironment (TME) comprises diverse cellular and non-cellular elements critical for tumor pathogenesis, growth, and metastasis.
- Long noncoding RNAs (lncRNAs), RNA molecules exceeding 200 nucleotides, are implicated in numerous physiological and pathological processes.
- Emerging evidence highlights the significant role of lncRNAs in mediating tumor-TME interactions, thereby impacting cancer progression.
Purpose:
- To review current research on the role of lncRNAs within the tumor microenvironment.
- To discuss the potential of lncRNAs for early cancer diagnosis and treatment strategies.
- To identify future research directions, including specific lncRNA knockout methods and targeted in vivo delivery systems.
Summary:
- This review synthesizes the current understanding of lncRNAs in the tumor microenvironment.
- It explores how lncRNAs influence tumor progression and interact with the TME.
- The potential of lncRNAs as biomarkers for early cancer detection and as therapeutic targets is examined.
Impact:
- Highlights the critical role of lncRNAs in cancer biology and the tumor microenvironment.
- Suggests novel avenues for developing innovative diagnostic and therapeutic approaches for cancer.
- Underscores the need for further investigation into lncRNA-specific targeting and delivery mechanisms for clinical translation.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
03:18Non-LTR Retrotransposons
11.6K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.6K